TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test
Introduction
The TSEN54 gene is associated with a rare genetic disorder called pontocerebellar hypoplasia type 4 (PCH4). PCH4 is characterized by underdevelopment (hypoplasia) of the cerebellum and pons, leading to severe neurological abnormalities.
Test Details
The TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test is a neurology-focused genetic test offered by DNA Labs UAE. This test utilizes Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously and identify mutations or variations in the DNA sequence.
Components
- Test Name: TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test, it is recommended to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with TSEN54 Gene Pontocerebellar hypoplasia type 4.
Benefits of Genetic Testing
Genetic testing can provide valuable information for patients and their families. It can confirm a diagnosis, guide medical management, and provide information about the likelihood of passing on the condition to future generations. It is important to consult with a genetic counselor or healthcare professional to understand the implications and limitations of genetic testing.
For individuals with a family history of PCH4, the TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test can also be used for carrier testing. This test can identify whether they carry a mutation in the TSEN54 gene.
Conclusion
The TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test offered by DNA Labs UAE is a valuable tool for diagnosing individuals suspected of having PCH4 and for carrier testing in individuals with a family history of the condition. With its use of NGS technology, this test can analyze multiple genes simultaneously and provide important information for patients and their families.
Test Name | TSEN54 Gene Pontocerebellar hypoplasia type 4 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for TSEN54 Gene Pontocerebellar hypoplasia type 4 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TSEN54 Gene Pontocerebellar hypoplasia type 4 |
Test Details |
The TSEN54 gene is associated with a rare genetic disorder called pontocerebellar hypoplasia type 4 (PCH4). PCH4 is characterized by underdevelopment (hypoplasia) of the cerebellum and pons, leading to severe neurological abnormalities. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify mutations or variations in the DNA sequence. In the case of PCH4, NGS genetic testing can be used to detect mutations in the TSEN54 gene. By analyzing the TSEN54 gene, NGS genetic testing can help diagnose individuals suspected of having PCH4. It can also be used for carrier testing in individuals with a family history of PCH4, as it can identify whether they carry a mutation in the TSEN54 gene. Genetic testing can provide valuable information for patients and their families, including confirming a diagnosis, guiding medical management, and providing information about the likelihood of passing on the condition to future generations. It is important to consult with a genetic counselor or healthcare professional to understand the implications and limitations of genetic testing. |